back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-08-14 21:39 Tx date 2026-08-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-512,440
-8,000 vol $64.06 each |
1,870 | |
| Filed 2026-08-14 21:23 Tx date 2026-08-11 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-2,000 vol |
0 | |
| Filed 2026-08-14 20:46 Tx date 2026-05-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$25,830
+3,500 vol $7.38 each |
8,641 | |
| Filed 2026-08-14 20:37 Tx date 2026-05-12 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-3,500 vol |
122,529 | |
| Filed 2026-06-05 15:28 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,593 vol |
1,593 | |
| Filed 2026-06-05 15:27 Tx date 2026-06-03 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,507 vol |
136,536 | |
| Filed 2026-06-05 15:25 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
59 - Exercise for cash
|
-1,416 vol |
0 | |
| Filed 2026-06-05 15:23 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,229 vol |
6,370 | |
| Filed 2026-06-05 15:21 Tx date 2026-06-01 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,229 vol |
1,416 | |
| Filed 2025-06-10 13:24 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+2,645 vol |
2,645 | |
| Filed 2025-06-10 13:23 Tx date 2015-05-21 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-06-10 13:21 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+17,012 vol |
126,029 | |
| Filed 2025-06-10 13:09 Tx date 2025-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-91.44
-3 vol $30.48 each |
5,141 | |
| Filed 2025-05-20 12:18 Tx date 2025-05-14 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-5,144 vol |
109,017 | |
| Filed 2025-05-20 12:00 Tx date 2025-05-14 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$64,660
+5,144 vol $12.57 each |
5,144 | |
| Filed 2024-06-07 14:21 Tx date 2024-06-05 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$593,082
+15,542 vol $38.16 each |
114,161 | |
| Filed 2024-06-05 10:26 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-141,011 vol |
0 | |
| Filed 2024-06-05 10:26 Tx date 2024-06-04 |
$FUSN
Fusion Pharmaceuticals Inc. |
Gannon, Steven Richard
4 - Director of Issuer
Direct Ownership
|
Options
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
-81,000 vol |
0 | |
| Filed 2024-03-13 17:50 Tx date 2024-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-92,402.40
-2,000 vol $46.20 each |
2,000 | |
| Filed 2024-03-13 17:50 Tx date 2024-03-07 |
$XENE
Xenon Pharmaceuticals Inc. |
Gannon, Steven
4 - Director of Issuer
Holder: 9465-2138 Québec inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-231,512.50
-5,000 vol $46.30 each |
4,000 |